Protein Z-dependent protease inhibitor/protein Z complex, a new target for hemophilia treatment
Journal of Translational Science · 2021 · 7 (1)
DOI: 10.15761/jts.1000391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Science, 2021. Verfasst von Xin Huang. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Protein Z-dependent protease inhibitor (ZPI), a serpin family protein, together with its tightly bound vitamin K-dependent protein cofactor, protein Z (PZ), function to rapidly and specifically inhibit membrane-bound FXa.Along with antithrombin, tissue factor pathway inhibitor (TFPI), and activated protein C (APC), the ZPI/PZ complex comprises one of the major endogenous anticoagulants in human plasma.Recent findings showing that ZPI/PZ regulates prothrombinase activity and that ZPI/PZ gene knockout partly restores hemostasis in a hemophilia mouse model have suggested that the neutralization of ZPI/PZ anticoagulant function could provide an alternative therapy for hemophilia treatment.Compared with other alternative therapies currently in development that target APC, TFPI, and antithrombin anticoagulants, anti-ZPI/PZ therapy is expected to be safer and similarly effective.Recent progress in the development of potent, specific ZPI/PZ antagonists should enable testing of this potentially safer therapy in a hemophilia mouse model.
Zitieren
APA
Huang, X. (2021). Protein Z-dependent protease inhibitor/protein Z complex, a new target for hemophilia treatment. Journal of Translational Science, 7(1). https://doi.org/10.15761/jts.1000391
Vancouver
Huang X. Protein Z-dependent protease inhibitor/protein Z complex, a new target for hemophilia treatment. Journal of Translational Science. 2021;7(1). doi:10.15761/jts.1000391
BibTeX
@article{Huang2021,
author = {Huang, Xin},
title = {Protein Z-dependent protease inhibitor/protein Z complex, a new target for hemophilia treatment},
journal = {Journal of Translational Science},
year = {2021},
volume = {7},
number = {1},
doi = {10.15761/jts.1000391}
}
EUVIMED